In the TCGA-BLCA cohort of muscle-invasive bladder cancer, NECTIN4 amplifications were also not associated with disease-specific survival and OS (Appendix Fig A3A and A3B). This evidence concerns the gene NECTIN4 and bladder transitional cell carcinoma.